Needle Biopsy Market Size, Share Report, Analysis, Trends, Growth, 2030

Needle Biopsy Market

Needle Biopsy Market by Type (Core Needle Biopsy, Fine- Needle Aspiration Biopsy, Vacuum- Assisted Biopsy, Image- Guided Biopsy) by Utility (Disposable, Reusable) by Application (Tumor, Infection, Inflammation, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-5852 Published Date: Feb-2021 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 614.40 Million USD 892.40 Million 5.48% 2019

Global Needle Biopsy Industry Perspective:

The needle biopsy market size is set for rapid growth over the forecast period. In terms of revenue, the global needle biopsy market accounted for USD 614.40 Million in 2019 and is expected to reach USD 892.40 Million by 2026, growing at a CAGR of 5.48%.

The report analyzes the global needle biopsy market drivers, restraints/challenges, and the effect they have on the demand during the projection period. In addition, the report explores emerging opportunities in the needle biopsy industry.              

Global Needle Biopsy Market: Overview

Needle biopsy is a medical diagnostic method used to obtain suspected tissue samples from the body for diagnosis/diagnosis of exclusion. Tissue samples accumulated from biopsy devices are sent to laboratory testing for analysis and diagnosis of various diseases. In order to categorize or assess the staging of diseases and rule out the existence of particular diseases, these tissue samples are analyzed.

Global Needle Biopsy MarketRequest Free Sample

Global Needle Biopsy Market: Growth Factors

The needle biopsy market is mainly driven by the production of goods and the decline in the prices of raw materials and components. Rising cases of cancer and the increasing use of biopsy needles are fueling market growth. Companies should concentrate on improving distribution quality in order to reduce price pressures due to massive market fragmentation. Distribution deals between major players and innovative goods, such as multi-layer needles, would be highly beneficial. The increase in the global geriatric population and government measures to spread cancer awareness are also expected to boost market growth.

Needle biopsy provides non-invasive screening procedures to diagnose cancer by using liquids such as saliva, urine, blood, etc. to detect malignancy. Technological change may enhance the ability of needle biopsy and can substitute needle biopsy techniques. In needle biopsy, real-time progression of cancers is also feasible, raising the degree of danger to needle biopsy. It is expected that the dropping cost of goods due to greater fragmentation of the market and the rise of Chinese companies would bring additional pressure on prices. The growth of the needle biopsy market is challenged by increasing strict regulations and requirements for medical devices, and the uncertainty regarding reimbursement in the United States.

Global Needle Biopsy Market: Segmentation

The two fundamental forms of needle biopsies include fine aspiration needle biopsy and core needle biopsy. Core needle biopsy is a hollow needle measuring between 11 and 18 gauge and is used to extract a sample of tissue from the liver, breast, prostate, and other organs. Local anesthesia is used to make the region numb until the tissue sample is collected. Fine needle aspiration typically needs a small hollow needle varying from 22–27-gauge needle to acquire just a small proportion of the damaged area. Fine needle biopsy is most widely used for the processing of thyroid samples.

Needle-based biopsy guns are a lucrative strategy that many players are pursuing. Core needle biopsy has greater efficiency and detectability than fine needle aspiration biopsy. The use of core needle biopsy to achieve the highest sensitivity and detectability in combination with needle aspiration biopsy is increasingly prevalent. As a consequence, the two tests are complementary and the efficiency rate is highest with both tests being performed together.

Vacuum-assisted needle biopsy is expected to be the fastest-growing category. Rising rates of cancer screening in the world would stimulate the market. Among different types of cancer, breast cancer is expected to lead to the greatest use of needle biopsy.

GlobalNeedle BiopsyMarket: Report Scope

Report Attributes Report Details
Report Name Needle Biopsy Market Research Report
Market Size in 2019 USD 614.40 Million
Market Forecast in 2026 USD 892.40 Million
Growth Rate CAGR of 5.48%
Number of Pages 255
Forecast Units Value (USD Billion), and Volume (Units)
Key Companies Covered Boston Scientific Corporation, CareFusion Corporation, Cook Medical, Hologic, Inc, C. R. Bard, Inc, Medax, BD Hakko co. ltd, Moller Medical GmbH, and Argon Medical Devices, Inc. among others.
Segments Covered By Type, By Utility, By Application, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)
Base Year 2019
Historical Year 2017 to 2019
Forecast Year 2020 - 2026
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Needle Biopsy Market: Regional Analysis

By Geography, the needle biopsy market is segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

North America dominated the global demand for needle biopsy in 2019, followed by Europe. In 2019, the United States held the largest market share for needle biopsy in the region, due to the involvement of key players, technical innovations, growing adoption of needle biopsy, increased spending on health care, and appropriate reimbursement policies.

Europe is the second largest market due to high disposable incomes and increased awareness. Another market-driven factor in the region is the expanded implementation of national cancer screening programs and the rising acceptance of high-priced devices. In addition, increased coverage of refunds for biopsy processes and favorable demographics are other aspects of boosting market growth in the region.

The needle biopsy market in Asia Pacific is likely to expand at the highest CAGR during the forecast period. The growth of the market in the region can be attributed to the early adoption of advanced technologies such as core needle biopsy, fine-needle aspiration biopsy, etc., increased awareness, huge health expenditure, and high penetration of research activities across the region.

The Middle East & Africa market is dominated by Gulf nations, especially the UAE, and Saudi Arabia. Poor regions of Africa are expected to be lagging behind due to poor economic and political stability and a weak public healthcare system.

Global Needle Biopsy Market: Competitive Players

The major players in the global needle biopsy market include

  • Boston Scientific Corporation
  • CareFusion Corporation
  • Cook Medical
  • Hologic. Inc
  • C. R. Bard. Inc
  • Medax
  • BD Hakko co. ltd
  • Moller Medical GmbH
  • Argon Medical Devices.Inc. 
  • among others.

The report segment of the global needle biopsy market is as follows:

Global Needle Biopsy Market: Type Segment Analysis

  • Core Needle Biopsy
  • Fine- Needle Aspiration Biopsy
  • Vacuum- Assisted Biopsy
  • Image- Guided Biopsy

Global Needle Biopsy Market: Utility Segment Analysis

  • Disposable
  • Reusable

Global Needle Biopsy Market: Application Segment Analysis

Global Needle Biopsy Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

The needle biopsy market is mainly driven by the production of goods and the decline in the prices of raw materials and components. Rising cases of cancer and the increasing use of biopsy needles are fueling market growth. Companies should concentrate on improving distribution quality in order to reduce price pressures due to massive market fragmentation. Distribution deals between major players and innovative goods, such as multi-layer needles, would be highly beneficial. The increase in the global geriatric population and government measures to spread cancer awareness are also expected to boost market growth.

According to Zion Market Research, the Needle Biopsy market size is expected to generate revenue of around USD 892.40 Million by the end of 2026, growing at a CAGR of 5.48%.

By Geography, the needle biopsy market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America dominated the global demand for needle biopsy in 2019, followed by Europe. In 2019, the United States held the largest market share for needle biopsy in the region, due to the involvement of key players, technical innovations, growing adoption of needle biopsy, increased spending on health care and appropriate reimbursement policies.

Europe is the second largest market due to high disposable incomes and increased awareness. Another market-driven factor in the region is the expanded implementation of national cancer screening programs and the rising acceptance of high-priced devices. In addition, increased coverage of refunds for biopsy processes and favorable demographics are other aspects of boosting market growth in the region.

The needle biopsy market in Asia Pacific is likely to expand at a highest CAGR during the forecast period. The growth of the market in the region can be attributed to the early adoption of advanced technologies such as core needle biopsy, fine-needle aspiration biopsy, etc., increased awareness, huge health expenditure, and high penetration of research activities across the region.

The Middle East & Africa market is dominated by gulf nations, especially the UAE, and Saudi Arabia. Poor regions of Africa are expected to be lagging behind due to poor economic and political stability and weak public healthcare system.

The major players in the global needle biopsy market include Boston Scientific Corporation, CareFusion Corporation, Cook Medical, Hologic, Inc, C. R. Bard, Inc, Medax, BD Hakko co. ltd, Moller Medical GmbH, and Argon Medical Devices, Inc. among others.

 

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed